Related references
Note: Only part of the references are listed.Identification of an epitope derived from CML66, a novel tumor-associated antigen expressed broadly in human leukemia, recognized by human leukocyte antigen-A*2402-restricted cytotoxic T lymphocytes
Koichiro Suemori et al.
CANCER SCIENCE (2008)
Effects of the aurora kinase inhibitors AZD1152-HQPA and ZM447439 on growth arrest and polyploidy in acute myeloid leukemia cell lines and primary blasts
Elisabeth Walsby et al.
HAEMATOLOGICA (2008)
Aurora kinase inhibitory VX-680 increases Bax/Bcl-2 ratio and induces apoptosis in Aurora-A-high acute myeloid leukemia
Xue-Fei Huang et al.
BLOOD (2008)
Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies
Katayoun Rezvani et al.
BLOOD (2008)
VX-680 inhibits Aurora A and Aurora B kinase activity in human cells
Rebecca K. Tyler et al.
CELL CYCLE (2007)
Aurora-a, a negative prognostic marker, increases migration and decreases radiosensitivity in cancer cells
Zhong Guan et al.
CANCER RESEARCH (2007)
AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo
Jing Yang et al.
BLOOD (2007)
Overexpression of the centrosomal protein Aurora-A kinase is associated with poor prognosis in epithelial ovarian cancer patients
Charles N. Landen et al.
CLINICAL CANCER RESEARCH (2007)
A novel treatment strategy targeting Aurora kinases in acute myelogenous leukemia
Takayuki Ikezoe et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Targeting aurora kinases as therapy in multiple myeloma
Yijiang Shi et al.
BLOOD (2007)
Translational mini-review series on vaccines: Peptide vaccines for myeloid leukaemias
A. J. Barrett et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase
Mark G. Manfredi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Molecular signature of CD34+ hematopoietic stem and progenitor cells of patients with CML in chronic phase
E. Diaz-Blanco et al.
LEUKEMIA (2007)
Aurora-A: the maker and breaker of spindle poles
Alexis R. Barr et al.
JOURNAL OF CELL SCIENCE (2007)
Aurora kinases: New targets for cancer therapy
Richard D. Carvajal et al.
CLINICAL CANCER RESEARCH (2006)
Aurora kinase A messenger RNA overexpression is correlated with tumor progression and shortened survival in head and neck squamous cell carcinoma
Rudolf Reiter et al.
CLINICAL CANCER RESEARCH (2006)
Analysis of Aurora-A and hMPS1 mitotic kinases in mantle cell lymphoma
E Camacho et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Aurora kinases
VM Bolanos-Garcia
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2005)
Aurora kinases, aneuploidy and cancer, a coincidence or a real link?
R Giet et al.
TRENDS IN CELL BIOLOGY (2005)
RNA interference targeting aurora kinase A suppresses tumor growth and enhances the taxane chemosensitivity in human pancreatic cancer cells
T Hata et al.
CANCER RESEARCH (2005)
Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression
Y Oka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Cancer immunotherapy: moving beyond current vaccines
SA Rosenberg et al.
NATURE MEDICINE (2004)
Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53
H Katayama et al.
NATURE GENETICS (2004)
Myeloma cells are highly sensitive to the granule exocytosis pathway mediated by WT1-specific cytotoxic T lymphocytes
T Azuma et al.
CLINICAL CANCER RESEARCH (2004)
AuroraA overexpression overrides the mitotic spindle checkpoint triggered by nocodazole, a microtubule destabilizer
Y Jiang et al.
ONCOGENE (2003)
The cellular geography of aurora kinases
M Carmena et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Aurora2/BTAK/STK15 is involved in cell cycle checkpoint and cell survival of aggressive non-Hodgkin's lymphoma
M Hamada et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Function and regulation of Aurora/Ipl1p kinase family in cell division
YW Ke et al.
CELL RESEARCH (2003)
Tetramer-assisted identification and characterization of epitopes recognized by HLAA*2402-restricted Epstein-Barr virus-specific CD8+ T cells
K Kuzushima et al.
BLOOD (2003)
AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol
S Anand et al.
CANCER CELL (2003)
Two distinct HLA-A0201-presented epitopes of the Wilms tumor antigen can function as targets for leukemia-reactive CTL
I Bellantuono et al.
BLOOD (2002)
Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53-/- cells
P Meraldi et al.
EMBO JOURNAL (2002)
Efficient identification of HLA-A*2402-restricted cytomegalovirus-specific CD8+ T-cell epitopes by a computer algorithm and an enzyme-linked immunospot assay
K Kuzushima et al.
BLOOD (2001)
Tumour-amplified kinase BTAK is amplified and overexpressed in gastric cancers with possible involvement in aneuploid formation
C Sakakura et al.
BRITISH JOURNAL OF CANCER (2001)
Share Paper
